<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35365499</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Archives of disease in childhood</Title><ISOAbbreviation>Arch Dis Child</ISOAbbreviation></Journal><ArticleTitle>Long COVID (post-COVID-19 condition) in children: a modified Delphi process.</ArticleTitle><Pagination><StartPage>674</StartPage><EndPage>680</EndPage><MedlinePgn>674-680</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/archdischild-2021-323624</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this study was to derive a research definition for 'Long COVID (post-COVID-19 condition)' in children and young people (CYP) to allow comparisons between research studies.</AbstractText><AbstractText Label="DESIGN">A three-phase online Delphi process was used, followed by a consensus meeting. Participants were presented with 49 statements in each phase and scored them from 1 to 9 based on how important they were for inclusion in the research definition of Long COVID in CYP. The consensus meeting was held to achieve representation across the stakeholder groups. Statements agreed at the consensus meeting were reviewed by participants in the Patient and Public Involvement (PPI) Research Advisory Group.</AbstractText><AbstractText Label="SETTING">The study was conducted remotely using online surveys and a virtual consensus meeting.</AbstractText><AbstractText Label="PARTICIPANTS">120 people with relevant expertise were divided into three panels according to their area of expertise: Service Delivery, Research (or combination of research and service delivery) and Lived Experience. The PPI Research Advisory group consisted of CYP aged 11-17 years.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Consensus was defined using existing guidelines. If consensus was achieved in two or more panels or was on the border between one and two panels, those statements were discussed and voted on at the consensus meeting.</AbstractText><AbstractText Label="RESULTS">Ten statements were taken forward for discussion in the consensus meeting and five statements met threshold to be included in the research definition of Long COVID among CYP. The research definition, aligned to the clinical case definition of the WHO, is proposed as follows: <i>Post-COVID-19 condition occurs in young people with a history of confirmed SARS-CoV-2 infection, with at least one persisting physical symptom for a minimum duration of 12 weeks after initial testing that cannot be explained by an alternative diagnosis. The symptoms have an impact on everyday functioning, may continue or develop after COVID infection, and may fluctuate or relapse over time</i>. The positive COVID-19 test referred to in this definition can be a lateral flow antigen test, a PCR test or an antibody test.</AbstractText><AbstractText Label="CONCLUSIONS">This is the first research definition of Long COVID (post-COVID-19 condition) in CYP and complements the clinical case definition in adults proposed by the WHO.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8871-7847</Identifier><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health Population, Policy and Practice, London, UK t.stephenson@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allin</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugawela</LastName><ForeName>Manjula D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health Population, Policy and Practice, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health Population, Policy and Practice, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health Population, Policy and Practice, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto Pereira</LastName><ForeName>Snehal</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0876-8757</Identifier><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing at UCL, UCL Great Ormond Street Institute of Child Health Library, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soni</LastName><ForeName>Manas</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Department of Medical Education, UCL Medical School, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Marian</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1984-4575</Identifier><AffiliationInfo><Affiliation>National Perinatal Epidemiology Unit, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Emily Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health Population, Policy and Practice, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-7358-9766</Identifier><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health Population, Policy and Practice, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CLoCk Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health Population, Policy and Practice, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P020372/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Dis Child</MedlineTA><NlmUniqueID>0372434</NlmUniqueID><ISSNLinking>0003-9888</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adolescent health</Keyword><Keyword MajorTopicYN="N">child health</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Buszewicz</LastName><ForeName>Martha</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chalder</LastName><ForeName>Trudie</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crawley</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stavola</LastName><ForeName>Bianca de</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Shruti</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hargreaves</LastName><ForeName>Dougal</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harnden</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levin</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Segal</LastName><ForeName>Terry</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Kishan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swann</LastName><ForeName>Olivia</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35365499</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pii">archdischild-2021-323624</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stephenson T, Pereira SP, Shafran R. Long COVID - the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study 2021.</Citation></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. . Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health 2021;5:708&#x2013;18. 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med 2021;27:1129&#x2013;30. 10.1038/s41591-021-01402-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01402-w</ArticleId><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>
ONS . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK, 2021. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2september2021
</Citation></Reference><Reference><Citation>
NIHR . NIHR themed review: living with Covid19, 2020. Available: https://evidence.nihr.ac.uk/themedreview/living-with-covid19/ [Accessed 22 May 2021].</Citation></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. . Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis 2021;73:e4058&#x2013;63. 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, et al. . Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA 2021. 10.1001/jama.2021.11880. [Epub ahead of print: 15 Jul 2021].</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, et al. . Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect 2021;149:e32. 10.1017/S0950268821000145</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>
NICE . COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2020. Available: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-66142028400325
</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 2021;53:737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J 2021;40:e482&#x2013;7. 10.1097/INF.0000000000003328</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC . Post-COVID conditions, 2021. Available: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=Post%2DCOVID%20conditions%20are%20a,can%20have%20post%2DCOVID%20conditions
</Citation></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, et al. . Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J 2022;59:2101341. 10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al. . Preliminary evidence on long COVID in children. Acta Paediatr 2021;110:2208&#x2013;11. 10.1111/apa.15870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, et al. . Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr 2022. 10.1007/s00431-021-04345-z. [Epub ahead of print: 09 Jan 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejwani V, Chang H-Y, Tran AP, et al. . A multistakeholder Delphi consensus core outcome set for clinical trials in moderate-to-severe asthma (coreASTHMA). Ann Allergy Asthma Immunol 2021;127:116&#x2013;22. 10.1016/j.anai.2021.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.03.022</ArticleId><ArticleId IdType="pubmed">33781936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherratt FC, Allin BSR, Kirkham JJ, et al. . Core outcome set for uncomplicated acute appendicitis in children and young people. Br J Surg 2020;107:1013&#x2013;22. 10.1002/bjs.11508</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.11508</ArticleId><ArticleId IdType="pmc">PMC7317752</ArticleId><ArticleId IdType="pubmed">32181505</ArticleId></ArticleIdList></Reference><Reference><Citation>Allin BSR, Bradnock T, Kenny S, et al. . NETS1HD study: development of a Hirschsprung's disease core outcome set. Arch Dis Child 2017;102:1143&#x2013;51. 10.1136/archdischild-2017-312901</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2017-312901</ArticleId><ArticleId IdType="pmc">PMC5754863</ArticleId><ArticleId IdType="pubmed">28784616</ArticleId></ArticleIdList></Reference><Reference><Citation>Fish R, Sanders C, Adams R, et al. . A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. Lancet Gastroenterol Hepatol 2018;3:865&#x2013;73. 10.1016/S2468-1253(18)30264-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(18)30264-4</ArticleId><ArticleId IdType="pubmed">30507470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly LE, Shan F, MacVicar S, et al. . A core outcome set for neonatal opioid withdrawal syndrome. Pediatrics 2020;146. 10.1542/peds.2020-0018. [Epub ahead of print: 03 06 2020].</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0018</ArticleId><ArticleId IdType="pubmed">32493710</ArticleId></ArticleIdList></Reference><Reference><Citation>Allin BSR, Hall NJ, Ross AR, et al. . Development of a gastroschisis core outcome set. Arch Dis Child Fetal Neonatal Ed 2019;104:F76&#x2013;82. 10.1136/archdischild-2017-314560</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2017-314560</ArticleId><ArticleId IdType="pmc">PMC6762000</ArticleId><ArticleId IdType="pubmed">29540463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch KJ, Allin B, Jolly M, et al. . Developing a set of consensus indicators to support maternity service quality improvement: using core outcome set methodology including a Delphi process. BJOG 2018;125:1612&#x2013;8. 10.1111/1471-0528.15282</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.15282</ArticleId><ArticleId IdType="pmc">PMC6220866</ArticleId><ArticleId IdType="pubmed">29770557</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood R, Allin B, Jones CE, et al. . A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health 2021;5:133&#x2013;41. 10.1016/S2352-4642(20)30304-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30304-7</ArticleId><ArticleId IdType="pmc">PMC7500943</ArticleId><ArticleId IdType="pubmed">32956615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokkink LB, van der Lee JH, Grootenhuis MA, et al. . Defining chronic diseases and health conditions in childhood (0-18 years of age): National consensus in the Netherlands. Eur J Pediatr 2008;167:1441&#x2013;7. 10.1007/s00431-008-0697-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-008-0697-y</ArticleId><ArticleId IdType="pubmed">18340463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierle DM, Aakre CA, Grach SL, et al. . Central sensitization phenotypes in post acute sequelae of SARS-CoV-2 infection (PASC): defining the post COVID syndrome. J Prim Care Community Health 2021;12:215013272110308. 10.1177/21501327211030826</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211030826</ArticleId><ArticleId IdType="pmc">PMC8267019</ArticleId><ArticleId IdType="pubmed">34231404</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Thompson P, Weiringa S, et al. . What items should be included in an early warning score for remote assessment of suspected COVID-19? qualitative and Delphi study. BMJ Open 2020;10:e042626. 10.1136/bmjopen-2020-042626</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-042626</ArticleId><ArticleId IdType="pmc">PMC7662139</ArticleId><ArticleId IdType="pubmed">33184088</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . A clinical case definition of post COVID-19 condition by a Delphi consensus, 2021. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [Accessed 13 Oct 2021].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>
NICE . COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2021. Available: https://app.magicapp.org/#/guideline/EQpzKn/section/n3vwoL
</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson PR, Altman DG, Bagley H, et al. . The COMET Handbook: version 1.0. Trials 2017;18:280. 10.1186/s13063-017-1978-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-017-1978-4</ArticleId><ArticleId IdType="pmc">PMC5499094</ArticleId><ArticleId IdType="pubmed">28681707</ArticleId></ArticleIdList></Reference><Reference><Citation>
NHS . When to self-isolate and what to do, 2021. Available: https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-and-treatment/when-to-self-isolate-and-what-to-do/
</Citation></Reference><Reference><Citation>
Limesurvey , 2021. Available: http://www.limesurvey.org
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>